- Play for free
- Guide
-
Quick Nav
- Learn to Play
- Contractors
- Create Contractor
- Graveyard
- Gifts
- Create Gift
- Stock Gifts
- Community
-
Discord Server
- Looking for Game
- Find a Playgroup
- Hall of Fame
- Website
-
Get Early Access
- Buy Merchandise
- News and Updates
Completed Contract
hyperraumsprung
ran
Bobasaurus
This Contract took place in Die Donauwelle on Apr 23, 2025 at 2:30PM
Attendance
Rosi Ramschgold has not yet spent their Gift for this Contract.
hat Boba in der Vergangenheit getrunken, ist fokussiert auf Schlichtung statt Combat
Eugen „die qualle“ fischbach has not yet spent their Gift for this Contract.
gutes Roleplaying, wurde als einziger nicht gebissen, führt sich in der Öffentlichkeit bisschen auf -> ist fast die Zeit mit gezogener Armbrust rumgelaufen
Gordian Gore has not yet spent their Gift for this Contract.
hat perfekt geroleplayed, wurde von dem Alien gebissen, hat mehrere Polizeieinsätze unter Flaschaussage ausgelöst (Vertuschung von eigener "Straftat" -> Schießerei vor dem Laden, auf der Flucht -> "Schießerei in entgegengesetzer Richtung zur Fluchtroute)
rAIner has not yet spent their Gift for this Contract.
hat zwei Bobas getrunken, hat sich den Arm beim E-Scooter Sturz gebrochen, rastet in Menschenmassen leicht aus
Gen-Wyld: Beyond Natural
On March 14, 2018, a little-known company named Gen-Wyld announced FDA approval for a groundbreaking procedure to enhance a patient’s primary and secondary sexual characteristics using gene therapy. The company was an overnight success.
Shortly thereafter, they introduced a suite of gene-altering body modification procedures that allowed patients to make dramatic aesthetic changes to their bodies by gene-splicing “non-human” anatomy. Those daring (and wealthy) enough can now add cuttlefish pigmentation to their skin, sport a pair of fox ears, and even add a functional tail. While rare, these so-called “modders” draw plenty of hate from conservative communities.
Thanks to their revolutionary procedures, Gen-Wyld is now a household name. Norman Carlson, Gen-Wyld’s chief evangelist, recently announced the company is in the trial phase for a groundbreaking treatment for diabetes.
Yet despite their success, a shroud of secrecy surrounds Gen-Wyld. Their no-patent policy obscures the secrets of their procedures from the public eye. Financial experts claim that Gen-Wyld is run less like a traditional business and more like an NGO with some specific, unknown objective.
Some claim that they will not stop until humanity has been reduced to monstrous slaves and that Gen-Wyld’s board of directors will install themselves as inhuman overlords of the new world order.
However, until the true secrets behind Gen-Wyld are discovered, the genetic biotech firm will continue to grow, develop, and progress its grand designs.